Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium

Ultrasound Obstet Gynecol. 2018 Sep;52(3):295-296. doi: 10.1002/uog.19186. Epub 2018 Aug 6.
No abstract available

MeSH terms

  • Early Termination of Clinical Trials
  • Female
  • Fetal Growth Retardation / drug therapy*
  • Humans
  • Hypertension, Pulmonary / chemically induced
  • Infant, Newborn
  • Phosphodiesterase 5 Inhibitors / adverse effects*
  • Placenta / drug effects
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Sildenafil Citrate / adverse effects*
  • Withholding Treatment

Substances

  • Phosphodiesterase 5 Inhibitors
  • Sildenafil Citrate